Global Phase I CRO (Clinical Research Organization) Benchmarking Report 2022: Insights from 186 Experienced Phase I Outsourcers and 540+ Service Provider Encounters
Dublin, May 09, 2022 (GLOBE NEWSWIRE) -- The "Phase I CRO Benchmarking (14th Ed.)" report has been added to ResearchAndMarkets.com's offering.
The CRO Benchmarking report has been designed with two goals. The first is to help sponsors make more informed CRO selections. It can be challenging to find the right fit for a particular sponsor organization or trial. And without prior experience with a CRO, it is difficult to judge how the CRO will perform.
186 experienced Phase I outsourcers shared their insights regarding 547 recent service provider encounters. The publisher analyzed a variety of factors around CRO selection and share performance data for 32 CROs on 22 attributes across several categories (Budget Factors, Delivery Factors, Staff Characteristics, Accessibility, and Services).
The second goal of the report is to help CROs optimize operational and marketing strategies. Learning your customers' assessments of your strengths and weaknesses can be invaluable for both the development and marketing of a successful offering. With this report, you'll understand in which areas your company's performance shines and in which areas you may need to close the gap relative to competitors. These insights can then be used to design marketing materials that effectively promote your company's strengths and differentiators.
What you will learn:
Sponsors:
Learn which service providers your company should keep in mind for your clinical development programs by identifying how individual CROs have performed for your peers
Better understand CRO customer loyalty based on overall customer satisfaction, willingness to recommend, and likelihood to use again
Discover which Phase I-specific attributes motivate outsourcing selection, and evaluate verbatim responses from recent customers on CRO performance
CROs:
Understand how recent customers have rated your company's performance across 22 attributes
Learn how to improve your marketing messaging by focusing on the areas in which customers say you excel compared to the competition
Read verbatim customer rationale for their satisfaction level with your company's performance
Find out which factors affect sponsor outsourcing preferences, and which factors are gaining in importance for future outsourcing
Key Topics Covered:
Service Provider Selection Process
Primary Section Takeaways
Preferred Provider Agreements
Selection Attributes
Use of Outside Consultants for CRO
Identification and Selection
Service Provider Perceptions and Interactions
Primary Section Takeaways
Phase I Leadership, Familiarity, and Reported Use
Service Provider Preference
Service Provider Preference among Users
Cost Perceptions
Cost Experience among Users
Summary Table
Service Provider Performance and Loyalty
Primary Section Takeaways
Budget Factors
Delivery Factors
Staff Characteristics
Accessibility
Services
A Note on Harvey Ball Calculations
Performance Across Service Providers
CRO Performance: Budget Factors
CRO Performance: Delivery Factors
CRO Performance: Staff Characteristics
CRO Performance: Accessibility
CRO Performance: Services
Customer Loyalty: 2022
Customer Loyalty: 3-Year Rolling Average
Company Service Quality Profiles
Study Data
Phase I Leaders, Unprompted
Other Responses
Phase I Leaders, Prompted
Service Provider Familiarity
Service Provider Familiarity - Additional Providers
Service Provider Reported Usage
Service Provider Preference
Service Provider Differentiation
Service Provider Cost Perceptions
Use of Preferred Providers
Number of Preferred Providers
Selection Drivers: Selecting among
Preferred Providers
Preferred Provider Attributes Gaining Importance
Selection Drivers: When Not Using
Preferred Providers
Selection Drivers: No Preferred Providers
Service Provider Attributes Gaining Importance:
No Preferred Providers
Use of Outside Consultants for CRO Identification
and Selection
Service Provider Drill-downs
Altasciences (Algorithme, Vince, WCCT)
BioPharma Services Inc
Biotrial
Catalyst Clinical Research
Celerion
CHDR
Covance/Labcorp
CTI Clinical Trial & Consulting
DCRI-Duke
Eurofins (including bioskin)
Frontage
ICON (including PRA)
Innovaderm
Questions about this report
IQVIA
Lambda
Medpace
NAMSA (including Clinlogix)
Novotech
Novum
Nuvisan
Parexel
Pharm-Olam International
PPD
Precision for Medicine
QPS
Quotient Clinical
SGS Life Sciences
Siro Clinpharm
Spaulding Clinical
Syneos Health (including Synteract)
TKL Research
Worldwide Clinical Trials
Demographics
Company Type
Office Location
Job Title
Decision-making Responsibility
Outsourcing Involvement by Phase
Involvement in Clinical Development
Therapeutic Areas of Responsibility
Years of Industry Experience
For more information about this report visit https://www.researchandmarkets.com/r/5tyywk
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900